Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

NCT02583373 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia
Pneumococcal Infections

Interventions

DRUG: CAL02 Low-dose
DRUG: CAL02 High-dose
DRUG: Placebo

Sponsor

Combioxin SA